Trexquant Investment LP Invests $1.54 Million in Ardent Health, Inc. $ARDT

Key Points

• Trexquant Investment LP has invested approximately $1.54 million in Ardent Health, acquiring 111,758 shares during the first quarter, representing about 0.08% of the company's stock.
• Ardent Health recently reported earnings per share (EPS) of $0.52, surpassing the consensus estimate of $0.30, and set their fiscal year 2025 guidance with an expected EPS range of 1.730-2.01.
• Wall Street analysts have mixed views on Ardent Health, with an average target price of $19.56 and various ratings from "strong-buy" to "underperform" as per multiple analyst reports.

Trexquant Investment LP bought a new stake in Ardent Health, Inc. (NYSE:ARDT - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund bought 111,758 shares of the company's stock, valued at approximately $1,537,000. Trexquant Investment LP owned 0.08% of Ardent Health at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in ARDT. Vanguard Group Inc. raised its position in Ardent Health by 368.9% during the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company's stock worth $18,296,000 after acquiring an additional 1,046,845 shares during the period. Nuveen LLC acquired a new position in Ardent Health during the first quarter worth $6,010,000. Walleye Capital LLC acquired a new position in Ardent Health during the first quarter worth $1,831,000. Point72 Asset Management L.P. raised its position in Ardent Health by 7.9% during the fourth quarter. Point72 Asset Management L.P. now owns 1,609,720 shares of the company's stock worth $27,494,000 after acquiring an additional 117,421 shares during the period. Finally, Nuveen Asset Management LLC raised its position in Ardent Health by 220.6% during the fourth quarter. Nuveen Asset Management LLC now owns 169,475 shares of the company's stock worth $2,895,000 after acquiring an additional 116,610 shares during the period.

Ardent Health Price Performance

Shares of Ardent Health stock traded up $0.21 during trading hours on Thursday, reaching $13.24. 336,891 shares of the company's stock were exchanged, compared to its average volume of 271,535. Ardent Health, Inc. has a 1 year low of $10.10 and a 1 year high of $20.72. The company has a market capitalization of $1.89 billion, a P/E ratio of 7.31, a price-to-earnings-growth ratio of 5.76 and a beta of 0.30. The business has a fifty day moving average of $12.32 and a two-hundred day moving average of $13.15. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, research analysts predict that Ardent Health, Inc. will post 1.23 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ARDT has been the subject of a number of research analyst reports. UBS Group initiated coverage on shares of Ardent Health in a research report on Wednesday. They set a "buy" rating and a $17.00 price objective for the company. Bank of America lowered shares of Ardent Health from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $15.50 to $14.60 in a report on Wednesday, July 16th. JPMorgan Chase & Co. dropped their target price on shares of Ardent Health from $18.00 to $15.00 and set a "neutral" rating for the company in a report on Monday, August 11th. Stephens reaffirmed an "overweight" rating and set a $21.00 target price on shares of Ardent Health in a report on Tuesday, May 20th. Finally, Wall Street Zen raised shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Nine analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $19.33.

Ardent Health Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.